Financial Health Assessment: THE CHEAM GROUP PLC

1. Financial Health Score: B-

Explanation: Without the complete "blood work" (detailed profit & loss and balance sheet figures), a perfect score is impossible to assign. However, the patient exhibits excellent regulatory hygiene and a robust corporate structure. The score of B- reflects a structurally sound entity with a long history of survival, though the lack of explicit financial vitals in the current chart means underlying financial conditions cannot be definitively ruled out.

2. Key Vital Signs

• Corporate Lifespan (Incorporation Date): 28 November 1990. At over 30 years old, this business has survived multiple economic cycles, indicating a strong constitution and long-term viability.
• Regulatory Immune System (Filing Compliance): Accounts and Confirmation Statements are fully up to date with no overdue filings. This indicates a healthy administrative immune system with no symptoms of regulatory distress or neglect.
• Bone Density (Share Capital): £818,342.95. This is a substantial share capital foundation, well above the minimum requirements for a Public Limited Company (PLC), suggesting the business was seeded with significant structural strength.
• Genetic Makeup (Corporate Structure): A Public Limited Company (PLC) operating as a head office (SIC 70100), which is 75-100% owned by East Surrey Holdings Limited. This means the company is part of a larger corporate "family" and likely acts as a central nervous system for the group.

3. Symptoms Analysis

• Positive Symptoms: The company is active, compliant, and filing full (rather than abbreviated or dormant) accounts. The presence of a designated Finance and Regulation Director (Paul Kerr) points to a formalized approach to financial and statutory health.
• Potential Underlying Conditions: As a head office functioning within a larger group structure, its individual health is intrinsically tied to the circulatory system of its parent (East Surrey Holdings Limited). The company’s own cash flow and profitability are likely dependent on inter-company management fees or group dividends. Additionally, Paul Kerr serves a dual role as both Finance Director and Company Secretary; while not uncommon, this concentration of financial and compliance oversight can sometimes be a symptom of a lean organization where internal controls could be at risk of strain.

4. Diagnosis

Structurally sound but financially opaque. The Cheam Group PLC acts as the central nervous system for broader group operations. The absence of detailed financial metrics (such as net current assets, net assets, or P&L reserves) in the current data set means we cannot measure its cardiovascular health (cash flow) or check for financial anemia (low liquidity). However, based on its compliance record and substantial share capital, there are no immediate, visible symptoms of acute financial distress.

5. Prognosis

Stable, but entirely dependent on the health of the parent. Because East Surrey Holdings Limited owns more than 75% of the company, The Cheam Group PLC's future outlook is inextricably linked to the parent company's financial wellness. If the parent remains healthy, the subsidiary is well-positioned to continue operating effectively.

6. Recommendations

1. Order Full Blood Work: Retrieve the full, filed annual accounts from Companies House to review the detailed balance sheet and profit & loss figures. This is essential to check working capital levels and ensure the "blood flow" (cash) is healthy.
2. Check the Parent's Heartbeat: Conduct a financial health check on East Surrey Holdings Limited. Because the parent provides the company's life support, any financial arrhythmia at the parent level will immediately impact this subsidiary.
3. Review Internal Controls: Evaluate the dual role held by Paul Kerr (Finance Director and Secretary). Ensure there are sufficient checks and balances in place to prevent compliance or financial fatigue from concentrated responsibilities.